ARCHIVED NEWS

Health Sciences Acquisitions Corporation 2 Announces Closing of Upsized $160 Million Initial Public Offering, Including Full Exercise of the Underwriters’ Over-Allotment Option

Health Sciences Acquisitions Corporation 2 (Nasdaq: HSAQ, the "Company" or "HSAC 2") announced today that it closed its initial public offering of 16,000,000 ordinary shares, which included the full exercise of the underwriters' over-allotment option.

RTW Investments, LP, Ji Xing Pharmaceuticals and Cytokinetics Enter Into Strategic Financing Collaboration to Support the Development of CK-274 and Enter China

RTW Investments, a global, full life-cycle investor provides a multi-faceted capital solution to support Cytokinetics’ development of CK-274; including direct equity investment, royalty monetization, and royalty-backed development funding.

RTW Charitable Foundation donates to New York Cares, Weill Cornell and UNICEF

The RTW Charitable Foundation (“RTWCF”) is pleased to announce it has made three donations in May and June 2020. RTWCF was particularly motivated to rally around organizations providing relief to those affected by the COVID-19 pandemic.

RTW Venture Fund spoke to the Association of Investment Companies (AIC) about the impact COVID-19 will have on our industry

With vast swathes of the world in lockdown, the one question on everyone’s minds is how long will it take to develop a vaccine against COVID-19? The Association of Investment Companies (AIC) has spoken to investment company and VCT managers about the prospects for a vaccine and how their portfolio companies are contributing to the fight against coronavirus.